Showing results (291-300 of 427) with videos related to

Sort By:
Pageof 43
British Journal of Haematology|October 28, 2008
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemiaRoberto Latagliata, Massimo Breccia, Paola Fazi, et al.
Haematologica|December 4, 2025
Rapid and accurate identification of acute promyelocytic leukemia with a novel multiparametric flow cytometric scoring systemAlessandro Laganà, David Fanciullo, Deborah Kasmi, et al.
European Journal of Haematology|June 14, 2018
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?Roberto Latagliata, Massimo Breccia, Ida Carmosino, et al.
Annals of Hematology|April 21, 2018
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practiceMassimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, et al.
European Journal of Haematology|May 29, 2015
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemiaMaria Teresa Voso, Pasquale Niscola, Alfonso Piciocchi, et al.
Cancers|October 14, 2022
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life ExperienceMatteo Molica, Carla Mazzone, Pasquale Niscola, et al.
Haematologica|October 8, 2008
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-upFrancesca Palandri, Fausto Castagnetti, Nicoletta Testoni, et al.
American Journal of Hematology|February 1, 2014
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patientsMarco Montanaro, Roberto Latagliata, Michele Cedrone, et al.
Annals of Hematology|September 18, 2012
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II studyEsther Natalie Oliva, Maria Cuzzola, Maria Antonietta Aloe Spiriti, et al.
British Journal of Haematology|July 15, 2011
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factorsRoberto Latagliata, Massimo Breccia, Paola Fazi, et al.
Pageof 43